The awards honor and recognize the efforts, accomplishments and positive contributions of companies and individuals within the vaccine industry. SGS is particularly proud to have won the award at a time when organizations around the world are focusing all efforts on bringing vaccines and therapies quickly to market in the global fight against the COVID-19 pandemic.

Johan Pype, Managing Director Benelux, SGS, said: “We are extremely pleased to receive this prestigious award which celebrates our achievements in continually setting standards of excellence and advocacy in the vaccine industry. At a time when we are working closely with so many of our honored peers, partners and clients to safely and effectively unlock the world from this pandemic, I’d like to express my thanks for their nominations and support in achieving this welcome recognition.”

SGS Life Sciences has extensive experience in Infectious Diseases and currently supports multiple SARS-CoV-2 studies from its Clinical Pharmacology Unit in Antwerp, as well as across international settings. The company provides clinical research, bioanalytical, biologics characterization, biosafety, and quality control testing. Its clinical trial (phase I to IV) services encompass clinical project management and monitoring, biometrics, PK/PD modeling and simulation, including viral and malaria modeling to tackle real world problems.

The virtual ‘ViE Awards’ took place as part of World Vaccine Congress 2020 (September 29 – October 1, 2020), where winners from all 12 award categories were announced via video. The annual event addresses commercial and scientific issues involving regulation, strategy, manufacturing, trials, partnering, influenza, cancer, emerging diseases and veterinary vaccines.